Skip to main content
SpringerLink
Log in

Long Term Outcomes of Intratympanic Dexamethasone in Intractable Unilateral Meniere’s Disease

Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Cite this article

Abstract

To evaluate the long term effect of Intratympanic dexamethasone in intractable Meniere’s disease. 30 patients with refractory Meniere’s disease which did not respond to the standard medical management, were treated with Intratympanic dexamethasone injections. Post treatment hearing outcome and dizziness scores were compared with the pretreatment values respectively. The mean dizziness handicap inventory (DHI) score was reduced from 91.58 (range 80–100) to be 31.00 (p = 0.00) at 3 months of treatment. With the successive follow-up periods, the mean DHI scores were reduced to 51.50, 46.6, and 50.90 at the end of, 6, 12, and 24 months (p = 0.04, 0.35, and 0.49 respectively). Again at the end of 24 months, 23.80% of patients were free of vertigo (p = 0.01). No patient had improvement in the hearing (> 10 dB) in any of the follow-up periods and 6.6% demonstrated deterioration in hearing. There were no major intraoperative or postoperative complications detected. Intratympanic injection of steroid is a safe and effective method for treating intractable Meniere’s disease. Although short term improvement in the vertigo is well documented, still in 23% of the patients were found to be free of vertigo at even the end of 24 months. There was no significant improvement in hearing noticed, either in short term or in long term.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Atlas MD, Chai F, Boscata L (1998) Meniere’s disease. Evidence of an immune process. Am J Otol 19:628–631

    CAS  PubMed  Google Scholar 

  2. Nagura M, Iwasaki S, Wu R, Mizuta K, Umemura K, Hoshino T (1999) Effect of corticosteroid contrast medium and ATP on focal microcirculatory disorders of the cochlea. Eur J Pharmacol 366:47–53

    Article  CAS  Google Scholar 

  3. Shirwany NA, Seidmann MD, Wenxue T (1998) Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 19:230–235

    CAS  PubMed  Google Scholar 

  4. Parnes LS, Sun A, Fremman DJ (1999) Corticosteroidpharmacokietics in the inner ear fluids: an animal study followed by clinical applications. Laryngoscope 109(Suppl 91):1–17

    Article  CAS  Google Scholar 

  5. Chandrashekhar SS, Rubinstein RY, Kwartler JA et al (2000) Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 122:521–528

    Google Scholar 

  6. Silverstein H, Isaacson JE, Olds MJ, Rowan PT, Rosenberg S (1998) Dexamethasone inner ear perfusion for the treatment of Meniere’sdisease: a prospective, randomized, double-blind, crossover trial. Am J Otol 19:196–201

    CAS  PubMed  Google Scholar 

  7. Casani AP, Piaggi P, Cerchiai N, Seccia V, Franceschini SS, Dallan I (2012) Intratympanic treatment of intractable unilateral Meniere disease: Gentamicin or dexamethasone? A randomized controlled trial. Otolaryngol Head Neck Surg 146:430–437

    Article  Google Scholar 

  8. Shea PF, Richey PA, Wan JY, Stevens SR (2012) Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere’s disease. Laryngoscope 122:204–211

    Article  CAS  Google Scholar 

  9. Boleas-Aguirre MS, Lin FR, Della Santina CC, Minor LB, Carey JP (2008) Longitudinal results with intratympanic dexamethasone in thetreatment of Meniere’s disease. Otol Neurotol 29:33–38

    Article  Google Scholar 

  10. Weckel A, Marx M, Esteve-Fraysse MJ (2017) Control of vertigo in Ménière’s disease by intratympanic dexamethasone. Eur Ann Otorhinolaryngol Head Neck Dis 28(17):30112–30116

    Google Scholar 

  11. Shea PF, Richey PA, Wan JY, Stevens SR (2012) Hearing results and quality of life after streptomycin/dexamethasone perfusion for meniere’s disease. Laryngoscope 122:204–211

    Article  CAS  Google Scholar 

  12. Phillips JS, Westerberg B (2011) Intratympanic steroids for Ménière’s disease or syndrome. Cochrane Database Syst Rev 6(7):CD008514. https://doi.org/10.1002/14651858.CD008514.pub2

    Article  Google Scholar 

  13. Hu A, Parnes L (2009) Intratympanic steroids for inner ear disorders: a review. Audiol Neurotol 14:373–382

    Article  CAS  Google Scholar 

  14. Barrs DM (2009) Intratympanic steroid injections for intractable Meniere’s disease. Laryngoscope 111:2100–2104

    Article  Google Scholar 

  15. Arriaga MS, Goldman S (1998) Hearing results of intratympanic steroid injection treatment of endolymphatic hydrops. Laryngoscope 108:1682–1685

    Article  CAS  Google Scholar 

  16. Leng Y, Liu B, Zhou R, Liu J, Liu D, Zhang SL, Kong WJ (2017) Repeated courses of intratympanic dexamethasone injection are effective for intractable Meniere’s disease. Acta Otolaryngol 137(2):154–160

    Article  CAS  Google Scholar 

  17. Martin Sanz E, Zschaeck C, Gonzalez M, Mato T, Rodrigañez L, Barona R, Sanz R (2013) Control of vertigo after intratympanic corticoid therapy for unilateral Ménière’s disease: a comparison of weekly versus daily fixed protocols. Otol Neurotol 34(8):1429–1433

    Article  Google Scholar 

  18. Hamid MA (2001) Intratympanic dexamethasone perfusion in Menieres disease. In: Presented at the spring meeting of the American Neurotology society, Palm Desert CA, p 12

Download references

Acknowledgements

This research has received no financial grant from any funding agency, commercial or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, 751019, India

    Pradeep Pradhan

  2. Department of Otorhinolaryngology, Safdarjung Hospital & Vardhmann Mahavir Medical College, Ansari Nagar, New Delhi, 110029, India

    Priti Lal

  3. Department of Otorhinolaryngology, Dr. RML Hospital, New Delhi, India

    Kanwar Sen

  4. Department of ENT and Head Neck Surgery, All India Institute of Medical Sciences, Bhubaneswar, Odisha, 751019, India

    Pradeep Pradhan

Authors
  1. Pradeep Pradhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Priti Lal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kanwar Sen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pradeep Pradhan.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pradhan, P., Lal, P. & Sen, K. Long Term Outcomes of Intratympanic Dexamethasone in Intractable Unilateral Meniere’s Disease. Indian J Otolaryngol Head Neck Surg 71 (Suppl 2), 1369–1373 (2019). https://doi.org/10.1007/s12070-018-1431-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-018-1431-3

Keywords

search

Navigation